Disease-related biomarkers are associated with extended progression free survival after treatment with NEO-PV-01 in combination with anti-PD1 in patients with metastatic cancers Meeting Abstract


Authors: Ott, P.; Govindan, R.; Naing, A.; Friedlander, T.; Margolin, K.; Lin, J.; Bhardwaj, N.; Hellmann, M.; Awad, M.; Wanamaker, A.; Cleary, L.; Rooney, M.; Scherer, J.; Bushway, M.; Moles, M.; Khondker, Z.; Gaynor, R.; Srinivasan, L.; Chi, A.; Greshock, J.; Hu-Lieskovan, S.
Abstract Title: Disease-related biomarkers are associated with extended progression free survival after treatment with NEO-PV-01 in combination with anti-PD1 in patients with metastatic cancers
Meeting Title: 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 7
Issue: Suppl. 1
Meeting Dates: 2019 Nov 6-10
Meeting Location: National Harbor, MD
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2019-11-01
Start Page: 282
Language: English
ACCESSION: WOS:000496473200857
PROVIDER: wos
PMCID: 31694725
PUBMED: PMC6833189
DOI: 10.1186/s40425-019-0763-1
Notes: Meeting Abstract: P437 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    412 Hellmann